Modus Therapeutics: SEVUSMART study of sevuparin in children with severe malaria published in Nature CommunicationsOctober 22, 2026
General Modus Therapeutics: SEVUSMART study of sevuparin in children with severe malaria published in Nature CommunicationsBy Healthcare Propulsion StaffOctober 22, 20260 Modus Therapeutics Holding AB (publ) announces that the manuscript based on the Phase Ib study SEVUSMART in severe malaria, lead-authored…
